Home » Topics » Regulatory » Patents

Patents
RSS

Lilly claims compounds for women's health

Oct. 18, 1996

Natural antitumor indanone reported by Sagami

Oct. 18, 1996

Eisai claims RXR agonists

Oct. 18, 1996

New antitumor agents from Sagami

Oct. 18, 1996

VCAM-1 inhibitors from Sagami

Oct. 18, 1996

Banyu reports natural antitumor agent

Oct. 18, 1996

HER2/neu peptide fragment provokes immune response against tumor cells

Oct. 18, 1996

Japanese researchers report new antitumor antibiotics

Oct. 18, 1996

Kyowa Hakko reports antiestrogenic agents

Oct. 18, 1996

New immunosuppressants disclosed by Merck & Co.

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...